Pharma Europe 2017 aims to provide a forum for international researchers from various areas of Pharmacy,Pharmaceutical sciences, by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Pharmacy meeting.

Track 1: Pharmacognosy and Phytochemistry

Pharmacognosy is the study of drugs derived from Plants and herbs and the other aspect of Pharmacognosy is Phytochemistry. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, molecular simulation, and exploratory development and Biochemistry.

Global sales of plant products was totally estimated us $60 billion in 2002 and is expected to get higher at 6.4 % average growth rate

Related Conferences:

7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

European Association of Employed Community Pharmacists in Europe | European Pharmaceutical Union | Pharmaceutical Group of the European Union | Pharmaceutical Society of Australia | The Pharmacy Guild of Australia | The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association

Track 2: Pharmacological Sciences

Pharmacology is concerned with various aspects of pharmacological sciences are Behavioural pharmacology, Medical Pharmacology, Cardiovascular pharmacology, Endocrine Pharmacology, Clinical pharmacology, Urogenital pharmacology, Pharmacokinetics, Neuropharmacology, Immune pharmacology, Cognitive models of the brain, Neural models of memory, Functional modes of the brain, Neuropsychology, Cognitive neuroscience and neurosystems.  

The drug market was valued at nearly $5.8 billion during  2011 and will reach nearly $5.7 billion during   2012.  Total value is expected to reach nearly $5.4 billion in  2017

Related Conferences:

 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 8th World Congress on Pharmacology and Toxicology July 24-26, 2017 Melbourne, Australia.

Canadian Society of Hospital Pharmacists | Chinese Pharmaceutical Association | Indian Pharmacist Association | Pharmaceutical Society of Ireland | The Pharmaceutical Association of Israel | Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius | Pharmaceutical Society Of New Zealand | Norwegian Pharmacy Association | Pakistan Pharmacists Association

Track 3: Drugs and Regulations

Drugs & Regulations are very important in aspects of Pharmaceutical sciences where it deals with Drug safety, Cost effectiveness, Drug rediscovery, Pharmaceutical services, Role of pharmacists, Radio Pharmaceuticals and Multiple drug use etc.  The regulation of drugs varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as is the case in Australia. The role of therapeutic goods regulation is designed mainly to protect the health and safety of the population.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association

Track 4: Pharmaceutical Chemistry

This track involves chemical aspects of identification, and then systematic, thorough synthetic alteration of new chemical entities to make them suitable for therapeutic use. It includes synthetic and computational aspects of the study of existing drugs and agents in development in relation to their bioactivities i.e., understanding their structure-activity relationships (SAR). Pharmaceutical chemistry is focused on quality aspects of medicines and aims to assure fitness for purpose of medicinal products.

The chemical industry is one of the world’s largest branches and has significant influence on many other industries. Total global chemical shipments are worth an enormous five billion U.S. dollars

Related Conferences:

11th International Conference on Pharmacoepidemiology and Clinical Research  July 06-08, 2017 Kuala Lumpur, Malaysia ; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA

American Society for Pharmacy Law | American Society of Consultant Pharmacists  | American Society of Consultant Pharmacists Foundation | American Society of Health-System Pharmacists | Professional Compounding Centers of America | American College of Clinical Pharmacy

Track 5: Types Of Pharmaceutical Formulations

Pharmaceutical formulations, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Preformulation involves the characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation. In dealing with protein pre-formulation, the important aspect is to understand the solution behavior of a given protein under a variety of stress conditions such as freeze/thaw, temperature, shear stress among others to identify mechanisms of degradation and therefore its mitigation

Related Conferences:

9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association | Canadian Society of Hospital Pharmacists | Chinese Pharmaceutical Association | Indian Pharmacist Association | Pharmaceutical Society of Ireland | The Pharmaceutical Association of Israel

Track 6: Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity.

Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

The global market for nanotechnology dots was estimated to generate $121.0 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018.

Related Conferences:

7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association |American Society for Pharmacy Law

Track 7: Novel Drug Delivery Systems

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio recognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bio conjugate chemistry, and molecular biology.

Related Conferences:

3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA;5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

American Society of Consultant Pharmacists  | American Society of Consultant Pharmacists Foundation | American Society of Health-System Pharmacists | Professional Compounding Centers of America | American College of Clinical Pharmacy

Track 8: Bio-Pharmaceutics

Bio Pharmaceutics plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery,  Sustained drug delivery system, Routes of administration, Fundamental drug development.

The global market for quantum dots (QDs) was estimated to generate $121 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018.

Related Conferences:

6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

European Pharmaceutical Union | Pharmaceutical Group of the European Union | Pharmaceutical Society of Australia | The Pharmacy Guild of Australia | The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association

Track 9: Bioinformatics

Bioinformatics has emerged out of the inputs of specialists from several different areas such as biology, biochemistry, biophysics, molecular biology, and biostatistics and computer science. Specially designed algorithms and organised computer databases are at the core of all bioinformatic operations.   Algorithms, that are necessarily complex, make voluminous data easy to handle for defined purposes, in an amazingly short time, a process that is humanly impossible.   

The global market for Bioinformatics is expected to  grow from nearly $2.3 billion in 2014 to nearly $3.4 billion in 2019, with a compound annual growth rate (CAGR) of 8.3% for the period of 2014-2019.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

European Association of Employed Community Pharmacists in Europe | The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association | Canadian Society of Hospital Pharmacists | Chinese Pharmaceutical Association | Indian Pharmacist Association | Pharmaceutical Society of Ireland | The Pharmaceutical Association of Israel  

Track 10: Genetics & Genetic Engineering

Genetics is the study of genes, heredity, and genetic variation in living beings. It is basically considered a field of biology, but it bisect often with many of the life sciences like Pharmaceutical Sciences. The other aspects of this are Genetic engineering, Biomedical Engineering, Genomics Proteomics, Clinical engineering, Tissue engineering, biomedical data engineering etc.

The global genetic engineering market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019).

Related Conferences:

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria 

Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius | Pharmaceutical Society Of New Zealand | Norwegian Pharmacy Association | Pakistan Pharmacists Association

Track 11: Pharmaceutical Packaging

Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meagre percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago. But of late, pharmaceutical packaging has quickly become an essential part of the drug delivery system as well as a core element of the marketing mix, through which manufacturers can differentiate their products from those of their competitors. As drug manufacturers approach the 21st century, they face a number of challenges that packaging can help them meet. The demand for pharmaceutical packaging is increasing and will continue to increase as companies rely more on packaging and labelling as media to protect and promote their products, increase patient compliance, and meet new regulations.

Related Conferences:

8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit April 17-18, 2017, Bali, Indonesia; ; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA 

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association |American Society for Pharmacy Law | American Society of Consultant Pharmacists  

Track 12: Radiopharmaceuticals

Radiopharmaceuticals used as Diagnostic and therapeutic agents. The main group of these compounds are used as the radio tracers to diagnose the diseased tissues in a body. The global radiopharmaceuticals market was worth US$3.8 billion in 2011 and is expected to be growing at a stupendous CAGR of 18.3% to reach a value of US$12.2 billion by 2018.

Related Conferences:

8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

American Society of Consultant Pharmacists Foundation | American Society of Health-System Pharmacists | Professional Compounding Centers of America | American College of Clinical Pharmacy

Track 13: Hospital Pharmacy

They are experts in the field of medicines and are not only responsible for the dispensing of prescriptions but also the purchase, manufacture and quality testing of all medicines used in a hospital. Many hospital pharmacists are qualified to prescribe in their own right. Pharmacists work closely with medical and nursing staff to ensure that patients receive the best treatment, advising on the selection, dose and administration route. They also provide help and advice to patients in all aspects of their medicines.

In 2013, there were 287,420 pharmacists and 362,690 pharmacy technicians in the United States. Since 2003, the number of pharmacists in the U.S. has fluctuated year to year, but overall has increased approximately 19 %in the last decade. The number of pharmacy technicians steadily increased in the same period, adding over 151,000 workers from 2003-2013.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Indian Pharmacist Association | Pharmaceutical Society of Ireland | The Pharmaceutical Association of Israel | Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius | Pharmaceutical Society Of New Zealand | Norwegian Pharmacy Association | Pakistan Pharmacists Association

Track 14: Industrial Pharmacy

Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.

The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. TheUnited States alone holds some 40 per cent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association |American Society for Pharmacy Law | American Society of Consultant Pharmacists

Track 15: Ethics in Pharmacy

Ethics in pharmacy is also very important for the any Pharma Practitioner weather they are from industry or from research institutes or Hospital Pharmacists. Following are the few aspects one must be aware of during the drug discovery and development like NDA (New Drug Application), Adulteration, Misbranding, Exemption in prescription, Experimental animal ethics and Human trial.

Related Conferences:

8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA

Pharmaceutical Society Of New Zealand | Norwegian Pharmacy Association | Pakistan Pharmacists Association | National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association

Track 16: Pharma Consulting and Services

The Pharma consultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aims to increase the patient’s knowledge of their medication and improve their adherence to the regimen. Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets. Nanotechnology

Related Conferences:

World Pharma Congress, Nov 07-09, 2016 Las Vegas, Nevada, USA, International Conference on Pharma Marketing November 10-11, 2016 Alicante, Spain, 2^nd International Conference and Expo on Parenterals & Injectables, December 05-07, 2016 Dallas, TX, USA, 6^th World Pharmacists & Clinical Pharmacy Annual Congress, May 22-24, 2017 Chicago, USA, 8^th Global Pharmacovigilance & Drug Safety Summit, April 17-18, 2017 Bali, Indonesia, 7^th European Biosimilars Congress, May 15-17, 2017 Munich, Germany, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa

The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association | Canadian Society of Hospital Pharmacists | Chinese Pharmaceutical Association | Indian Pharmacist Association | Pharmaceutical Society of Ireland | The Pharmaceutical Association of Israel | Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius

Track 17: Entrepreneurs Investment Meet

Entrepreneurs Investment Meet is an effective platform where Entrepreneurs, investors, Pharma Experts meet to share their experiences, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. The meeting is the best opportunity to reach the largest assemblage of participants from the Pharma community.

ConferenceSeries Ltd invites all the participants across the globe to attend 9^th Annual European Pharma Congress during June 26-28, 2017 in Madrid, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Europe-2017 is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Latest Updates of European Pharmaceutical Policies: The Impact of developing and Marketing Drugs, its Registration & Approval” which covers a wide range of critically important sessions. 

Why to Attend???

Meet Your Target Market with members from around the world focused on learning about Pharma, this is your single best opportunity to reach the largest assemblage of participants from the Pharma community. Conduct demonstrations, distribute information, meet with current and potential Scientists, make a splash with a new research, and receive name recognition at this 3-day Pharmaceutical Event.World-renowned speakers, the most recent techniques, tactics, and the newest updates in Pharmaceutical Sciences fields are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

Target Audience:

• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Graduates and Post Graduates
• Directors, CEO’s of Organizations
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Bio instruments Professionals
• Bio-informatics Professionals
• Software development companies
• Research Institutes and members
• Supply Chain companies
• Manufacturing Companies
• CRO and DATA management Companies
• Training Institutes
• Business Entrepreneurr

ConferenceSeries Ltd invites all the participants across the globe to attend 9^th Annual European Pharma Congress during June 26-28, 2017 in Madrid, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Europe 2017 is a specially designed cluster conference. The main theme of the conference is “Latest Updates of European Pharmaceutical Policies: The Impact of developing and Marketing Drugs, its Registration & Approval” which covers a wide range of critically important sessions.

Major Pharma Associations around the Globe:

Academy of Managed Care Pharmacy (AMCP), Alexandria, VA

American Association of Pakistani Pharmaceutical Scientists

British Columbia Pharmacy Association

California Pharmacists Association

Kansas Pharmacists Association

Ohio Pharmacists Association

Pharmacy Guild of Australia

Major Pharma Associations in Europe:

European Association of Pharma Biotechnology

Pharmaceutical Group of the European Union

European Federation of Pharmaceutical Industries and Associations

European Biopharmaceutical Enterprises

European Federation of Pharmaceutical Industries and Associations

European Biotechnology

Farmaindustria

European Pharmaceutical Union (EPU)

Pharmaceutical Group of the European Union (PGEU)

European Association of Employed Community Pharmacists in Europe (EPhEU)

Danish Association of Pharmaconomists

Norwegian Pharmacy Association

The Pharmaceutical Industry: A Key Asset to The European Economy

As driving medical progress by researching, developing and bringing new medicines that improve health and quality of life for patients around the world, the research-based pharmaceutical industry is a key asset of the European economy. It is one of Europe’s top performing high technology sectors.

PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE.

 All new medicines introduced into the market are the result of lengthy, costly and risky research and development (R&D) conducted by pharmaceutical companies: Certain key factors that decide the market value of a pharmaceutical product are:

â–  by the time a medicinal product reaches the market, an average of 12-13 years will have elapsed since the first synthesis of the new active substance;

â–  The cost of researching and developing a new chemical or biological entity was estimated at € 1,172 million ($ 1,506 million in year 2011 dollars) in 2012 (Mestre-ferrandiz et al, office of Health Economics, December 2012); â–  on average, only one to two of every 10,000 substances synthesised in laboratories will successfully pass all stages of development required to become a marketable medicine.

Hence the value of the product is set accordingly keeping in mind all such factors

Phases of  Research And Development Process:

PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE

The value of pharmaceutical research based on the amount of research funding in different countries in Europe can be compared from the table below

IMPORTANCE OF PHARMACEUTICAL R&D

In 2012 the pharmaceutical industry invested more than € 30,000 million in R&D in Europe. A decade of strong uS market dominance led to a shift of economic and research activity towards the uS from 1995-2005. Additionally, Europe is now facing increasing competition from emerging economies: rapid growth in the market and research environments in countries such as brazil and china are contributing to the move of economic and research activities to non-European markets. The geographical balance of the pharmaceutical market – and ultimately the R&D base – is likely to shift gradually towards emerging economies

Pharmaceutical R&D Expenditure - Annual Growth Rate %

PHARMACEUTICAL SALES

The world pharmaceutical market was worth an estimated € 655,222 million ($ 870,200 million) at ex-factory prices in 2013. The north american market (usa&canada) remained the world’s largest market with a 41.0% share, well ahead of europe and japan.

Breakdown of the World Pharmaceutical Market – 2013 Sales

PRICE STRUCTURE

Distribution margins, which are generally fixed by governments, and vat rates differ significantly from country to country in Europe. On average, approximately 34% of the retail price of a medicine reverts not to the manufacturer, but rather to the distributors (pharmacists and wholesalers) and the state.

Breakdown of the Retail Price Of A Medicine, 2012 (%)